
# Title 42 - Public Health
## Chapter IV - Centers for Medicare & Medicaid Services, Department of Health and Human Services
### Subchapter B - Medicare Program
#### PART 413 - PRINCIPLES OF REASONABLE COST REIMBURSEMENT; PAYMENT FOR END-STAGE RENAL DISEASE SERVICES; PROSPECTIVELY DETERMINED PAYMENT RATES FOR SKILLED NURSING FACILITIES; PAYMENT FOR ACUTE KIDNEY INJURY DIALYSIS
##### Subpart H - Payment for End-Stage Renal Disease (ESRD) Services
###### ยง 413.234 Drug designation process.
####### chemical combination,Type 2 NDA,Type 4 NDA,new,Type 2 NDA,

(C) An NDA for an active ingredient that is aof two or more previously approved or marketed active moieties that are linked by an ester bond is classified as a combination of aas described in paragraph (e)(5)(i) of this section, with aas described in paragraph (e)(5)(ii) of this section, if the active moieties have not been previously marketed or approved as a physical combination. If the physical combination has been previously marketed or approved, however, such a product would no longer be considered acombination and the NDA would thus be classified as aas described in paragraph (e)(5)(i) of this section.
